High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.5M
$3,496,925
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-02-18 | $62,573 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 SellΔOwn -11.6%
|
2026-02-18 | $86,639 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-02-18 | $67,970 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-02-18 | $103,191 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 SellΔOwn -16.4%
|
2026-01-20 | $132,737 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-01-20 | $152,333 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-12-17 | $70,393 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-12-17 | $83,862 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-12-17 | $18,622 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-12-17 | $61,925 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-12-17 | $72,722 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-12-17 | $15,985 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-11-17 | $55,850 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-11-17 | $72,267 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-11-17 | $77,715 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-11-17 | $69,216 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-10-15 | $119,539 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-10-15 | $19,760 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-10-15 | $111,429 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-10-15 | $31,001 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-09-17 | $1,037,101Large | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-09-17 | $37,624 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 SellΔOwn -42.7%
|
2025-09-17 | $917,542 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-09-17 | $18,930 | S | Form 4 |